Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
4,180.00
+175.00 (4.37%)
At close: Feb 27, 2026
-42.50% (1Y)
| Market Cap | 207.12B -47.5% |
| Revenue (ttm) | 66.40B -23.9% |
| Net Income | -28.37B |
| EPS | -566.79 |
| Shares Out | 49.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 387,079 |
| Average Volume | 714,349 |
| Open | 4,005.00 |
| Previous Close | 4,005.00 |
| Day's Range | 3,995.00 - 4,265.00 |
| 52-Week Range | 3,685.00 - 8,800.00 |
| Beta | -0.64 |
| RSI | 47.85 |
| Earnings Date | Mar 20, 2026 |